Risk Analyst

• Feb 2021 - Present

Preventieadviseur

• Apr 2018 - Jan 2021

Advisor to the management team. Responsible for all legal requirements according to the corresponding federal, regional and European Law. General safety management & well-being (approx. 800 FTE), safety committee, COVID crisis management, emergency planning (incl. training first response team, exercises, procedures, poc fire department, intervention plan), risk analysis, fire & explosion safety, chemical safety, industrial hygiene coordination, biological safety, physical agents, machine safety (2006/42/EC), incident analysis, personal protection, etc.

Health Safety Environment Coordinator

• Apr 2018 - Jan 2021

Advisor to the management team. Responsible for all legal requirements according to the corresponding federal, regional and European Law. Management of Change, REACH (EC 1907/2006), CLP (EC 1272/2008), chemical safety, SHEMS coordinator (management standards/system), security, risk analysis, industrial hygiene program (EN 689:2018), electromagnetic fields, KPI poc and reporting, audit (self, internal, corporate), COVID crisis management, etc. Advisor to the management team. Responsible for all legal requirements according to the corresponding federal, regional and European Law. Management of Change, REACH (EC 1907/2006), CLP (EC 1272/2008), chemical safety, SHEMS coordinator (management standards/system), security, risk analysis, industrial hygiene program (EN 689:2018), electromagnetic fields, KPI poc and reporting, audit (self, internal, corporate), COVID crisis management, etc.

Health and Safety Consultant

• Nov 2015 - Jan 2021

Fixed long-term assignments (multiple days/week/company) at: - ZF Group - SABIC - De Lijn (Vlaamse Vervoersmaatschappij) Fixed long-term assignments (multiple days/week/company) at: - ZF Group - SABIC - De Lijn (Vlaamse Vervoersmaatschappij)

Health Safety Environment Officer

• Jan 2016 - Apr 2018

Advisor to the management team. Responsible for all legal requirements according to the corresponding federal, regional and European Law. General safety management (approx. 1000 FTE) , multi-yearplanning, policy, safety committee, risk analysis (multilevel), machine safety (2006/42/EC), emergency planning, chemical safety, industrial hygiene coordination, electromagnetic fields, internal audit, incident analysis, physical agents, personal protection, etc. Advisor to the management team. Responsible for all legal requirements according to the corresponding federal, regional and European Law. General safety management (approx. 1000 FTE) , multi-yearplanning, policy, safety committee, risk analysis (multilevel), machine safety (2006/42/EC), emergency planning, chemical safety, industrial hygiene coordination, electromagnetic fields, internal audit, incident analysis, physical agents, personal protection, etc.

Research Associate - HSE Advisor

• Feb 2014 - Sep 2015

Acquisition of Okapi Sciences by Aratana Therapeutics Inc. Aratana Therapeutics NV is the Belgian affiliate of Aratana Therapeutics Inc. (Nasdaq: PETX), a US-based biopharmaceutical company focused on the licensing, development and commercialization of innovative Pet Therapeutics. At Aratana Therapeutics NV new pet therapeutics are discovered and developed with a focus on antiviral medicine for cats and dogs. • Responsible for the coordination, management and execution of in vitro studies for two antiviral projects • Responsible ADME/Tox Lab: development and implementation of different toxicological and pharmacological tests which are used in various research projects • Development and management of databases • Internal EHS officer responsible for the company policy regarding biosafety, occupational health and safety and environment in accordance with federal, regional and European law. • Advisor to the management team.

Scientist - HSE Advisor

• Dec 2008 - Jan 2014

Okapi Sciences aims to develop drugs to treat viral infections in both pets and livestock. Viral infections remain a threat to animal health and food production, as classical vaccination is often impossible, ineffective or unavailable. Okapi Sciences was acquired by Aratana Therapeutics on January 6, 2014. • Responsible for the coordination, management and execution of in vitro studies for two antiviral projects • Responsible ADME/Tox Lab: development and implementation of different toxicological and pharmacological tests which are used in various research projects • Development and management of databases • Internal EHS officer responsible for the company policy regarding biosafety, occupational health and safety and environment in accordance with federal, regional and European law. • Advisor to the management team.

Internship Project Engineer

• Aug 2007 - Jul 2008

• Optimization of analysis techniques (protein extraction) • Manufacturing process improvement (yield improvement, reducing waste) • Optimization of analysis techniques (protein extraction) • Manufacturing process improvement (yield improvement, reducing waste)